Quantitative Evaluation of the Breast's Morphological Variations During Radiotherapy: MorphoBreast3D
NCT03801850 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2020-08-12
Summary
Quantitative evaluation of the breast's morphological variations during radiotherapy consisting in performing three-dimensional surface acquisitions of the breast in order to study its shape and volume. Evaluation of the dosimetric impact of these variations.
Conditions
- Breast Cancer Female
- Adjuvant Radiotherapy
Interventions
- DEVICE
-
3D surface scan
measurement of inter fractional deformations by surface scanning
Sponsors & Collaborators
-
Centre Paul Strauss
lead OTHER
Principal Investigators
-
Georges NOEL, MD PhD · Centre Paul Strauss
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-22
- Primary Completion
- 2020-05-07
- Completion
- 2020-05-07
Countries
- France
Study Locations
More Related Trials
-
Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma
NCT04849871 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients
NCT03385031 ·Status: COMPLETED
-
Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer
NCT03568981 ·Status: UNKNOWN
-
Partial Breast Irradiation (PBI) for Selected Patients With Early Breast Cancer
NCT00325598 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast Cancer
NCT05850637 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
NCT00893035 ·Status: COMPLETED
-
Outcomes and Cosmesis With Whole Breast Irradiation and Boost
NCT06295744 ·Status: RECRUITING ·Phase: NA
-
Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients
NCT05350722 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Body Radiation Therapy for Breast Cancer
NCT03585621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy
NCT03738553 ·Status: TERMINATED
-
Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers
NCT02701348 ·Status: COMPLETED ·Phase: NA
-
4D CT Scan Versus 3D CT Scan Concerning Cardiac Dosimetry Assesment for Left Sided Breast Cancers Radiotherapy
NCT05726604 ·Status: UNKNOWN ·Phase: NA
-
Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer
NCT02482376 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening
NCT04273542 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prospective Radiomics Study for Breast Cancer
NCT06095414 ·Status: COMPLETED
-
Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer
NCT06418126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intraoperative Radiotherapy for Early Stage Breast Cancer
NCT01189851 ·Status: COMPLETED ·Phase: NA
-
Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
NCT02956473 ·Status: COMPLETED ·Phase: NA
-
Intensity Modulated Radiotherapy for Breast Cancer
NCT00594477 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost
NCT01591811 ·Status: COMPLETED ·Phase: PHASE3
-
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
NCT06879704 ·Status: RECRUITING ·Phase: NA
-
Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability
NCT06382818 ·Status: RECRUITING ·Phase: NA
-
Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer
NCT00749437 ·Status: COMPLETED ·Phase: PHASE1
-
Partial-Breast Radiation Therapy in Treating Women With Early-Stage Breast Cancer
NCT01008514 ·Status: WITHDRAWN ·Phase: PHASE2
-
Prediction of Individual Radiosensitivity During Radiotherapy for Breast Cancer Patients
NCT05566613 ·Status: UNKNOWN